Unidad de investigación neurovascular
UIN
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (7)
2023
-
APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke
Frontiers in Neurology, Vol. 14
-
Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial
JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788
2021
-
Defining a Target Population to Effectively Test a Neuroprotective Drug
Stroke, Vol. 52, Núm. 2, pp. 505-510
2011
-
Implication of the toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis
Annals of Neurology, Vol. 70, Núm. 4, pp. 634-645
2009
-
Plasma levels of 15d-PGJ2 are not altered in multiple sclerosis
European Journal of Neurology, Vol. 16, Núm. 11, pp. 1197-1201
2006
-
TNF-α converting enzyme (TACE) protein expression in different clinical subtypes of multiple sclerosis
Journal of Neurology, Vol. 253, Núm. 6, pp. 701-706
2003
-
Revisión de consenso. Neuroprotección farmacológica en la isquemia cerebral: ¿Es todavía una opción terapéutica?
Neurologia, Vol. 18, Núm. 7, pp. 368-384